Additional Information Open House Biologika Discount Agreements 2020 19 Peginterferon Beta 1APharmaceutical ProductsShort Description The Health Insurance Companies Involved Pursue The Goal Of Concluding Discount Agreements In Accordance With Section 130A 8 Of The Social Code Book V For The Active Ingredient Peginterferon Beta 1A With All Suitable Pharmaceutical Companies The Contract Is Concluded As Part Of The Open House Biologics Procedure Of The Health Insurance Companies Involved Individual Negotiations About The Content Of The Contract Are Not Conducted Uniform Terms Apply The Health Insurance Companies Involved Do Not Guarantee Individual Contractual Partners Any Exclusivity The Contract Term Is A Maximum Of 24 Months Starting On February 1 2021 Deviating From This The Contract Period At Hek And Hkk Does Not Begin Until 1 5 2021 The Contract Ends No Later Than January 31 2023 Regardless Of The Date Of The Conclusion Of The Contract All Further Information Can Be Found In The Participation And Contract Documents If The Patent Expires Before January 31 2023 The Contract Ends Automatically At The End Of The Month In Which The Patent Expires Deadline For Submission 20230131 23 58Type Of Buyer Body Governed By Public LawType Of Contract SuppliesType Of Procedure Open ProcedureRegulation European Union With Participation By Gpa CountriesType Of Bid Submission For All LotsAward Criteria The Most Economic Tender Disclaimer The Above Text Is Machine Translated For Accurate Information Kindly Refer The Original Document
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
